Nelson Capital Management’s Gilead Sciences GILD Stock Holding History

Nelson Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$274K	Sell	2,171 -760	-26%	-$100K	0.03%	105
2026 Q1	$408K	Buy	+2,931	New	+$410K	0.05%	90
2020 Q3	–	Sell	-73,930	Closed	-$5.69M	–	98
2020 Q2	$5.69M	Buy	73,930 +3,118	+4%	+$239K	1.24%	35
2020 Q1	$5.29M	Buy	70,812 +1,325	+2%	+$91.6K	1.42%	31
2019 Q4	$4.51M	Sell	69,487 -1,055	-1%	-$68.7K	0.95%	43
2019 Q3	$4.47M	Buy	70,542 +75	+0.1%	+$4.9K	1.06%	39
2019 Q2	$4.76M	Buy	70,467 +785	+1%	+$51.6K	1.13%	39
2019 Q1	$4.53M	Buy	69,682 +3,662	+6%	+$243K	1.13%	39
2018 Q4	$4.13M	Sell	66,020 -13,839	-17%	-$967K	1.15%	36
2018 Q3	$6.17M	Buy	79,859 +2,859	+4%	+$216K	1.42%	28
2018 Q2	$5.46M	Buy	77,000 +570	+0.7%	+$40.3K	1.4%	31
2018 Q1	$5.76M	Buy	76,430 +265	+0.3%	+$21.1K	1.49%	27
2017 Q4	$5.46M	Sell	76,165 -392	-0.5%	-$29.8K	1.7%	28
2017 Q3	$6.2M	Buy	76,557 +120	+0.2%	+$9.18K	2.04%	17
2017 Q2	$5.41M	Sell	76,437 -300	-0.4%	-$20K	1.83%	23
2017 Q1	$5.21M	Buy	76,737 +3,618	+5%	+$254K	1.75%	25
2016 Q4	$5.24M	Sell	73,119 -10,265	-12%	-$763K	1.83%	26
2016 Q3	$6.6M	Buy	83,384 +1,385	+2%	+$113K	2.34%	11
2016 Q2	$6.84M	Sell	81,999 -218	-0.3%	-$19.3K	2.57%	10
2016 Q1	$7.55M	Buy	82,217 +30,220	+58%	+$2.73M	2.85%	6
2015 Q4	$5.26M	Buy	51,997 +200	+0.4%	+$20.8K	2.02%	24
2015 Q3	$5.09M	Buy	51,797 +1,727	+3%	+$192K	1.95%	24
2015 Q2	$5.86M	Buy	50,070 +1,119	+2%	+$122K	2.12%	17
2015 Q1	$4.8M	Sell	48,951 -640	-1%	-$65K	1.73%	29
2014 Q4	$4.67M	Buy	49,591 +65	+0.1%	+$6.72K	1.73%	29
2014 Q3	$5.27M	Buy	49,526 +1,496	+3%	+$146K	1.99%	21
2014 Q2	$3.98M	Buy	48,030 +1,690	+4%	+$132K	1.59%	30
2014 Q1	$3.28M	Buy	46,340 +1,790	+4%	+$140K	1.44%	34
2013 Q4	$3.35M	Sell	44,550 -450	-1%	-$31.3K	1.49%	32
2013 Q3	$2.83M	Buy	45,000 +1,200	+3%	+$71.7K	1.35%	35
2013 Q2	$2.25M	Buy	+43,800	New	+$2.28M	1.15%	37

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Nelson Capital Management's GILD Position: Q2 2026 in Review

Nelson Capital Management reduced its Gilead Sciences (GILD) stake by 26% in Q2 2026, selling an estimated $100K and leaving 2,171 shares worth $274K. The position accounts for 0.03% of the portfolio, ranked #105.

Nelson Capital Management first reported a position in GILD in Q2 2013 and has held it in 31 quarters since. The position peaked at $7.55M in Q1 2016. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Nelson Capital Management held 2,171 shares of Gilead Sciences worth $274K as of Q2 2026.
Nelson Capital Management sold 760 Gilead Sciences shares in Q2 2026, an estimated $100K.
Gilead Sciences made up 0.03% of Nelson Capital Management's portfolio in Q2 2026, its #105 holding.
Nelson Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 31 quarters since.
Nelson Capital Management's Gilead Sciences position peaked at $7.55M in Q1 2016.
1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Nelson Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.